Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
This report describes a limited gene-disease association between TFB2M and autism spectrum disorder. A rare homozygous variant, c.790C>T (p.His264Tyr), was identified in two Korean siblings with ASD (PMID:30414672). The inheritance pattern is consistent with an autosomal recessive mode, with one additional affected relative observed through sibling segregation (PMID:30414672). Genetic evidence is based on this single-family case report where the variant was detected by whole-exome sequencing, and its potential pathogenicity is further supported by experimental studies.
Functional assessments in patient-derived fibroblasts revealed augmented mitochondrial gene transcription and enhanced mitochondrial function, including increased ATP production and reactive oxygen species levels (PMID:30414672). These in vitro findings indicate that the c.790C>T (p.His264Tyr) variant may disrupt mitochondrial metabolic regulation, contributing to the disease phenotype. While current evidence is limited by the small sample size, the integrated genetic and functional data provide a basis for further investigation and potential diagnostic use.
Gene–Disease AssociationLimitedTwo affected siblings were identified with the homozygous c.790C>T (p.His264Tyr) variant and supportive segregation evidence in one family (PMID:30414672). Genetic EvidenceLimitedThe case report presents two probands from a single family with a homozygous variant, representing limited genetic evidence despite concordant familial segregation (PMID:30414672). Functional EvidenceModerateMultiple in vitro assays in patient fibroblasts showed enhanced mitochondrial transcription and function, corroborating a potential gain-of-function mechanism for TFB2M in ASD (PMID:30414672). |